Department of Public Health, School of Health, Zahedan University of Medical Sciences, Zahedan, Iran.
Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Prim Care Diabetes. 2020 Aug;14(4):297-304. doi: 10.1016/j.pcd.2020.01.003. Epub 2020 Feb 7.
BACKGROUND & OBJECTIVES: Type 2 diabetes is increasing in both developed and developing countries due to popularity of western lifestyle and population structure. Then, this systematic review aimed to identify the prevalence and trend of diabetes in the Middle-East region.
We searched Google Scholar, PubMed and Medline from 2000 up to 2018. MeSH terms were a combination of "diabetes", "prevalence", "diabetes mellitus", "type 2 diabetes", "Name of Countries" and "Middle East". Pooled estimates were obtained by means of random effect models to account for variation between studies.
Of the initially 669 identified articles, a total of 50 reports with 4,263,662 subjects met inclusion criteria. The combined prevalence of diabetes in the region was about 14.6% (95% CI: 11.6-17.5) which varied from 2.6% (95% CI: 2.5-2.6) to 21.9 (95% CI: 16.8-17.5) amongst countries. Therefore, approximately a total of 46 million individuals are now suffering from diabetes in the Middle East based on above-mentioned pooled estimate.
The pattern and growing trend of diabetes during last 20 years in the study area is alarming and underline the point that maximal risk reduction for developing diabetes should be at the top of health priorities.
由于西方生活方式和人口结构的普及，2 型糖尿病在发达国家和发展中国家都呈上升趋势。因此，本系统评价旨在确定中东地区糖尿病的流行率和趋势。
我们检索了 2000 年至 2018 年期间的 Google Scholar、PubMed 和 Medline。MeSH 术语是“糖尿病”、“流行率”、“糖尿病”、“2 型糖尿病”、“国家名称”和“中东”的组合。采用随机效应模型汇总估计值，以解释研究之间的差异。
最初确定的 669 篇文章中，共有 50 篇报告，共纳入 4263662 名受试者。该地区的糖尿病总流行率约为 14.6%（95%CI：11.6-17.5），各国间差异从 2.6%（95%CI：2.5-2.6）到 21.9%（95%CI：16.8-17.5）不等。因此，根据上述汇总估计，目前中东地区约有 4600 万人患有糖尿病。
过去 20 年该地区糖尿病的流行模式和增长趋势令人担忧，这表明最大程度地降低糖尿病发病风险应成为卫生保健的首要重点。
